Clinical Pharmacokinetics of TKIs in Chinese Patients of Hepatitis B (HBV)
NCT03680183
·
clinicaltrials.gov ↗
UNKNOWN
Status
300
Enrollment
OTHER
Sponsor class
Conditions
Non Small Cell Lung Cancer
Hepatitis B
Interventions
DRUG:
Entecavir 1Mg Oral Tablet
Sponsor
Affiliated Cancer Hospital & Institute of Guangzhou Medical University